Capricor Therapeutics, Inc. SEC filings CAPR
Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 14, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2026 | May 22, 2025 |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2026 | Mar 10, 2026 |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| EFFECT | Filing | Sep 23, 2025 | — |
| CORRESP | Letter to the SEC | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| S-3 | Shelf registration | Sep 10, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 11, 2025 | Jul 11, 2025 |
| S-8 | Employee stock plan registration | Jun 16, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2025 | Apr 8, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| S-8 | Employee stock plan registration | Feb 5, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2024 | — |
| S-3 | Shelf registration | Oct 22, 2024 | — |
| 424B5 | Prospectus supplement | Oct 17, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 17, 2024 | Oct 16, 2024 |
| EFFECT | Filing | Oct 16, 2024 | — |
| 424B5 | Prospectus supplement | Oct 16, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 16, 2024 | Oct 16, 2024 |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| S-3/A | Filing | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 15, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 17, 2024 | Sep 16, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 15, 2024 | May 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2024 | Apr 29, 2024 |
| ARS | Annual report to shareholders | Apr 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 14, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2024 | May 14, 2024 |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| S-8 | Employee stock plan registration | Feb 16, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 424B5 | Prospectus supplement | Sep 29, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 29, 2023 | Sep 29, 2023 |
| FWP | Free writing prospectus | Sep 29, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2023 | Sep 1, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2023 | Jul 11, 2023 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jun 15, 2023 | Jun 12, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 15, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 17, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 7, 2023 | — |
| 10-K | Annual report | Mar 17, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2023 | Feb 10, 2023 |
| S-8 | Employee stock plan registration | Jan 31, 2023 | — |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Other events
|
Jul 19, 2022 | Jul 19, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 3, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEF 14A | Proxy statement | Apr 12, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Other events
|
Apr 1, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Mar 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| S-8 | Employee stock plan registration | Feb 17, 2022 | — |
| 8-K |
Current report
Material agreement
|
Jan 25, 2022 | Jan 24, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2021 | Sep 24, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2021 | Jul 23, 2021 |
| 424B5 | Prospectus supplement | Jun 21, 2021 | — |
| 8-K |
Current report
Other events
|
Jun 21, 2021 | Jun 21, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 11, 2021 |
| EFFECT | Filing | Jun 16, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| S-3/A | Filing | Jun 15, 2021 | — |
| CORRESP | Letter to the SEC | Jun 14, 2021 | — |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 30, 2021 | Apr 28, 2021 |
| DEF 14A | Proxy statement | Apr 20, 2021 | Jun 11, 2021 |
| UPLOAD | Letter from the SEC | Mar 19, 2021 | — |
| S-3 | Shelf registration | Mar 16, 2021 | — |
| 10-K | Annual report | Mar 15, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2021 | Mar 11, 2021 |
| S-8 | Employee stock plan registration | Feb 12, 2021 | — |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Aug 25, 2020 | Aug 19, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| S-8 | Employee stock plan registration | Jun 17, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2020 | May 28, 2020 |
| EFFECT | Filing | May 19, 2020 | — |
| 424B3 | Prospectus | May 19, 2020 | — |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| CORRESP | Letter to the SEC | May 15, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2020 | May 14, 2020 |
| 8-K |
Current report
Results of operations
|
May 14, 2020 | May 14, 2020 |
| UPLOAD | Letter from the SEC | May 14, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Other events
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Other events
|
May 7, 2020 | May 7, 2020 |
| S-3 | Shelf registration | May 7, 2020 | — |
| 424B5 | Prospectus supplement | May 4, 2020 | — |
| 8-K |
Current report
Other events
|
May 4, 2020 | Apr 29, 2020 |
| DEF 14A | Proxy statement | Apr 17, 2020 | Jun 5, 2020 |
| 10-K | Annual report | Mar 27, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Mar 26, 2020 | Mar 25, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2020 | Mar 18, 2020 |
| 8-K |
Current report
Other events
|
Mar 18, 2020 | Mar 13, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Other events
|
Dec 19, 2019 | Dec 19, 2019 |
| 424B4 | Prospectus | Dec 19, 2019 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 18, 2019 | Dec 17, 2019 |
| EFFECT | Filing | Dec 17, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2019 | Dec 16, 2019 |
| CORRESP | Letter to the SEC | Dec 13, 2019 | — |
| S-1/A | Amended registration statement | Dec 13, 2019 | — |
| S-1/A | Amended registration statement | Dec 13, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2019 | — |
| S-1 | Registration statement | Dec 5, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2019 | Nov 14, 2019 |
| 8-K |
Current report
Other events
|
Nov 14, 2019 | Nov 13, 2019 |
| 10-Q | Quarterly report | Nov 8, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2019 | Oct 7, 2019 |
| 424B5 | Prospectus supplement | Aug 29, 2019 | — |
| 8-K |
Current report
Other events
|
Aug 29, 2019 | Aug 28, 2019 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2019 | Aug 14, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 424B5 | Prospectus supplement | Jul 22, 2019 | — |
| 8-K |
Current report
Material agreement
|
Jul 22, 2019 | Jul 22, 2019 |
| EFFECT | Filing | Jul 18, 2019 | — |
| S-3/A | Filing | Jul 17, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2019 | Jul 15, 2019 |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| 8-K |
Current report
Other events
|
Jul 15, 2019 | Jul 15, 2019 |
| 8-K |
Current report
Other events
|
Jun 20, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 4, 2019 | Jun 4, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2019 | May 29, 2019 |
| 10-Q | Quarterly report | May 14, 2019 | Mar 31, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133869
- Former names
- Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.